Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Maralixibat chloride by Mirum Pharmaceuticals for Biliary Atresia: Likelihood of Approval
Maralixibat chloride is under clinical development by Mirum Pharmaceuticals and currently in Phase II for Biliary Atresia. According to GlobalData,...
Volixibat potassium by Mirum Pharmaceuticals for Primary Sclerosing Cholangitis: Likelihood of Approval
Volixibat potassium is under clinical development by Mirum Pharmaceuticals and currently in Phase II for Primary Sclerosing Cholangitis. According to...
Volixibat potassium by Mirum Pharmaceuticals for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
Volixibat potassium is under clinical development by Mirum Pharmaceuticals and currently in Phase II for Primary Biliary Cholangitis (Primary Biliary...
Chenodiol by Mirum Pharmaceuticals for Cerebrotendinous Xanthomatosis: Likelihood of Approval
Chenodiol is under clinical development by Mirum Pharmaceuticals and currently in Pre-Registration for Cerebrotendinous Xanthomatosis. According to GlobalData, Pre-Registration drugs...